Fungal Cell Gigantism during Mammalian Infection
The interaction between fungal pathogens with the host frequently results in morphological changes, such as hyphae formation. The encapsulated pathogenic fungus Cryptococcus neoformans is not considered a dimorphic fungus, and is predominantly found in host tissues as round yeast cells. However, there is a specific morphological change associated with cryptococcal infection that involves an increase in capsule volume. We now report another morphological change whereby gigantic cells are formed in tissue. The paper reports the phenotypic characterization of giant cells isolated from infected mice and the cellular changes associated with giant cell formation. C. neoformans infection in mice resulted in the appearance of giant cells with cell bodies up to 30 µm in diameter and capsules resistant to stripping with γ-radiation and organic solvents. The proportion of giant cells ranged from 10 to 80% of the total lung fungal burden, depending on infection time, individual mice, and correlated with the type of immune response. When placed on agar, giant cells budded to produce small daughter cells that traversed the capsule of the mother cell at the speed of 20–50 m/h. Giant cells with dimensions that approximated those in vivo were observed in vitro after prolonged culture in minimal media, and were the oldest in the culture, suggesting that giant cell formation is an aging-dependent phenomenon. Giant cells recovered from mice displayed polyploidy, suggesting a mechanism by which gigantism results from cell cycle progression without cell fission. Giant cell formation was dependent on cAMP, but not on Ras1. Real-time imaging showed that giant cells were engaged, but not engulfed by phagocytic cells. We describe a remarkable new strategy for C. neoformans to evade the immune response by enlarging cell size, and suggest that gigantism results from replication without fission, a phenomenon that may also occur with other fungal pathogens.
Vyšlo v časopise:
Fungal Cell Gigantism during Mammalian Infection. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000945
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000945
Souhrn
The interaction between fungal pathogens with the host frequently results in morphological changes, such as hyphae formation. The encapsulated pathogenic fungus Cryptococcus neoformans is not considered a dimorphic fungus, and is predominantly found in host tissues as round yeast cells. However, there is a specific morphological change associated with cryptococcal infection that involves an increase in capsule volume. We now report another morphological change whereby gigantic cells are formed in tissue. The paper reports the phenotypic characterization of giant cells isolated from infected mice and the cellular changes associated with giant cell formation. C. neoformans infection in mice resulted in the appearance of giant cells with cell bodies up to 30 µm in diameter and capsules resistant to stripping with γ-radiation and organic solvents. The proportion of giant cells ranged from 10 to 80% of the total lung fungal burden, depending on infection time, individual mice, and correlated with the type of immune response. When placed on agar, giant cells budded to produce small daughter cells that traversed the capsule of the mother cell at the speed of 20–50 m/h. Giant cells with dimensions that approximated those in vivo were observed in vitro after prolonged culture in minimal media, and were the oldest in the culture, suggesting that giant cell formation is an aging-dependent phenomenon. Giant cells recovered from mice displayed polyploidy, suggesting a mechanism by which gigantism results from cell cycle progression without cell fission. Giant cell formation was dependent on cAMP, but not on Ras1. Real-time imaging showed that giant cells were engaged, but not engulfed by phagocytic cells. We describe a remarkable new strategy for C. neoformans to evade the immune response by enlarging cell size, and suggest that gigantism results from replication without fission, a phenomenon that may also occur with other fungal pathogens.
Zdroje
1. CasadevallA
PirofskiLA
2003 The damage-response framework of microbial pathogenesis. Nat Rev Microbiol 1 17 24
2. WhitewayM
BachewichC
2007 Morphogenesis in Candida albicans. Annu Rev Microbiol 61 529 553
3. SudberyP
GowN
BermanJ
2004 The distinct morphogenic states of Candida albicans. Trends Microbiol 12 317 324
4. LiuH
2001 Transcriptional control of dimorphism in Candida albicans. Curr Opin Microbiol 4 728 735
5. MarescaB
KobayashiGS
1989 Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 53 186 209
6. KaneJ
1984 Conversion of Blastomyces dermatitidis to the yeast form at 37 degrees C and 26 degrees C. J Clin Microbiol 20 594 596
7. MarescaB
KobayashiGS
2000 Dimorphism in Histoplasma capsulatum and Blastomyces dermatitidis. Contrib Microbiol 5 201 216
8. ParkBI
WannemuehlerKA
MarstonBJ
GovenderN
PappasPG
2009 Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23 525 530
9. CasadevallA
PerfectJR
1998 Cryptococcus neoformans;
PressA
Washington DC ASM Press
10. CherniakR
1988 Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol 2 40 54
11. GoldmanDL
LeeSC
CasadevallA
1995 Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 63 3448 3453
12. LeeSC
CasadevallA
DicksonDW
1996 Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. Am J Pathol 148 1267 1274
13. VecchiarelliA
2007 Fungal capsular polysaccharide and T-cell suppression: the hidden nature of poor immunogenicity. Crit Rev Immunol 27 547 557
14. YauchLE
LamJS
LevitzSM
2006 Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog 2 e120
15. ZaragozaO
RodriguesML
De JesusM
FrasesS
DadachovaE
2009 The Capsule of the Fungal Pathogen Cryptococcus neoformans. Adv Appl Microbiol 68 133 216
16. McClellandEE
BernhardtP
CasadevallA
2006 Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun 74 1500 1504
17. ZaragozaO
CasadevallA
2004 Experimental modulation of capsule size in Cryptococcus neoformans. Biol Proced Online 6 10 15
18. FeldmesserM
KressY
CasadevallA
2001 Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147 2355 2365
19. MaxsonME
CookE
CasadevallA
ZaragozaO
2007 The volume and hydration of the Cryptococcus neoformans polysaccharide capsule. Fungal Genet Biol 44 180 186
20. ZaragozaO
TabordaCP
CasadevallA
2003 The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions. Euro J Immnunol 33 1957 1967
21. ZaragozaO
ChrismanCJ
CastelliMV
FrasesS
Cuenca-EstrellaM
2008 Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell Microbiol 10 2043 2057
22. CruickshankJG
CavillR
JelbertM
1973 Cryptococcus neoformans of unusual morphology. Appl Microbiol 25 309 312
23. D'SouzaCA
AlspaughJA
YueC
HarashimaT
CoxGM
2001 Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans. Mol Cell Biol 21 3179 3191
24. LoveGL
BoydGD
GreerDL
1985 Large Cryptococcus neoformans isolated from brain abscess. J Clin Microbiol 22 1068 1070
25. ZaragozaO
MihuC
CasadevallA
NosanchukJD
2005 Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infection. Antimicrob Agents Chemother 49 4358 4361
26. NosanchukJD
ValadonP
FeldmesserM
CasadevallA
1999 Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 19 745 750
27. RosasAL
NosanchukJD
FeldmesserM
CoxGM
McDadeHC
2000 Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 68 2845 2853
28. ChaskesS
FrasesS
CammerM
GerfenG
CasadevallA
2008 Growth and pigment production on D-tryptophan medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans. J Clin Microbiol 46 255 264
29. BryanRA
ZaragozaO
ZhangT
OrtizG
CasadevallA
2005 Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryot Cell 4 465 475
30. DembitzerHM
BuzaI
ReissF
1972 Biological and electron microscopic changes in gamma radiated Cryptococcus neoformans. Mycopathol Mycol Appl 47 307 315
31. GatesMA
ThorkildsonP
KozelTR
2004 Molecular architecture of the Cryptococcus neoformans capsule. Mol Microbiol 52 13 24
32. ZaragozaO
CasadevallA
2006 Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance. Cell Microbiol 8 1862 1876
33. RodriguesML
AlvarezM
FonsecaFL
CasadevallA
2008 Binding of the wheat germ lectin to Cryptococcus neoformans suggests an association of chitinlike structures with yeast budding and capsular glucuronoxylomannan. Eukaryot Cell 7 602 609
34. ZaragozaO
TelzakA
BryanRA
DadachovaE
CasadevallA
2006 The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding. Mol Microbiol 59 67 83
35. MiyajiM
NishimuraK
AjelloL
1985 Scanning electron microscope studies on the parasitic cycle of Coccidioides immitis. Mycopathologia 89 51 57
36. de HoogGS
GuarroJ
GenéJ
FiguerasMJ
2000 Atlas of Clinical Fungi;
de HoogGS
GuarroJ
GenéJ
FiguerasMJ
Utrecht, Reus Centraalbureau vor Schimmel Cultures, Universitat Rovira i Virgili
37. AlspaughJA
Pukkila-WorleyR
HarashimaT
CavalloLM
FunnellD
2002 Adenylyl cyclase functions downstream of the Galpha protein Gpa1 and controls mating and pathogenicity of Cryptococcus neoformans. Eukaryot Cell 1 75 84
38. AlspaughJA
CavalloLM
PerfectJR
HeitmanJ
2000 RAS1 regulates filamentation, mating and growth at high temperature of Cryptococcus neoformans. Mol Microbiol 36 352 365
39. AlvarezM
CasadevallA
2006 Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 16 2161 2165
40. AlvarezM
CasadevallA
2007 Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages. BMC Immunol 8 16
41. MaH
CroudaceJE
LammasDA
MayRC
2007 Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol 8 15
42. MaH
CroudaceJE
LammasDA
MayRC
2006 Expulsion of live pathogenic yeast by macrophages. Curr Biol 16 2156 2160
43. LuoY
AlvarezM
XiaL
CasadevallA
2008 The outcome of phagocytic cell division with infectious cargo depends on single phagosome formation. PLoS One 3 e3219
44. CleareW
CasadevallA
1999 Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. Med Mycol 37 235 243
45. AldeaM
GariE
ColominaN
2007 Control of cell cycle and cell growth by molecular chaperones. Cell Cycle 6 2599 2603
46. Sugimoto-ShirasuK
RobertsK
2003 “Big it up”: endoreduplication and cell-size control in plants. Curr Opin Plant Biol 6 544 553
47. GrebienF
DolznigH
BeugH
MullnerEW
2005 Cell size control: new evidence for a general mechanism. Cell Cycle 4 418 421
48. Cavalier-SmithT
1978 Nuclear volume control by nucleoskeletal DNA, selection for cell volume and cell growth rate, and the solution of the DNA C-value paradox. J Cell Sci 34 247 278
49. KondorosiE
RoudierF
GendreauE
2000 Plant cell-size control: growing by ploidy? Curr Opin Plant Biol 3 488 492
50. MendellJE
ClementsKD
ChoatJH
AngertER
2008 Extreme polyploidy in a large bacterium. Proc Natl Acad Sci U S A 105 6730 6734
51. MergaertP
UchiumiT
AlunniB
EvannoG
CheronA
2006 Eukaryotic control on bacterial cell cycle and differentiation in the Rhizobium-legume symbiosis. Proc Natl Acad Sci U S A 103 5230 5235
52. SheaJM
KechichianTB
LubertoC
Del PoetaM
2006 The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect Immun 74 5977 5988
53. MoyrandF
FontaineT
JanbonG
2007 Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence. Mol Microbiol 64 771 781
54. CharlierC
NielsenK
DaouS
BrigitteM
ChretienF
2009 Evidence For A Role Of Monocytes In Dissemination And Brain Invasion By Cryptococcus Neoformans. Infect Immun 77 120 127
55. KechichianTB
SheaJ
Del PoetaM
2007 Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun 75 4792 4798
56. ShaoX
MednickA
AlvarezM
van RooijenN
CasadevallA
2005 An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia. J Immunol 175 3244 3251
57. ZaragozaO
AlvarezM
TelzakA
RiveraJ
CasadevallA
2007 The relative susceptibility of mouse strains to pulmonary Cryptococcus neoformans infection is associated with pleiotropic differences in the immune response. Infect Immun 75 2729 2739
58. NosanchukJD
RosasAL
LeeSC
CasadevallA
2000 Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355 2049 2050
59. BottoneEJ
HorgaM
AbramsJ
1999 “Giant” blastoconidia of Candida albicans: morphologic presentation and concepts regarding their production. Diagn Microbiol Infect Dis 34 27 32
60. AlasioTM
LentoPA
BottoneEJ
2003 Giant blastoconidia of Candida albicans. A case report and review of the literature. Arch Pathol Lab Med 127 868 871
61. PerfectJR
LangSDR
DurackDT
1980 Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol 101 177 194
62. Kwon-ChungKJ
1976 Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 68 821 833
63. Garcia-RiveraJ
EisenmanHC
NosanchukJD
AisenP
ZaragozaO
2005 Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates. Fungal Genet Biol 42 989 998
64. FeldmesserM
KressY
NovikoffP
CasadevallA
2000 Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68 4225 4237
65. Glatman-FreedmanA
MartinJM
RiskaPF
BloomBR
CasadevallA
1996 Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria. J Clin Microbiol 34 2795 2802
66. MaxsonME
DadachovaE
CasadevallA
ZaragozaO
2007 Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell 6 95 109
67. CasadevallA
CleareW
FeldmesserM
Glatman-FreedmanA
GoldmanDL
1998 Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42 1437 1446
68. BreimanL
FriedmanJH
OlshenJH
StoneCG
1984 Classification and regression trees. Belmont Wadsworth International
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection